 Daniel Forsha
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 18 | 2024 | 81 | 4.500 |
Why?
| | Heart Ventricles | 11 | 2024 | 49 | 4.170 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2022 | 19 | 2.410 |
Why?
| | Ventricular Function, Right | 5 | 2023 | 9 | 1.610 |
Why?
| | Heart Defects, Congenital | 3 | 2023 | 81 | 1.560 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2023 | 20 | 1.550 |
Why?
| | Humans | 33 | 2024 | 6896 | 1.470 |
Why?
| | Ventricular Function, Left | 7 | 2024 | 28 | 1.470 |
Why?
| | Down Syndrome | 3 | 2023 | 39 | 1.240 |
Why?
| | Myocarditis | 3 | 2022 | 3 | 1.210 |
Why?
| | Elasticity Imaging Techniques | 4 | 2016 | 7 | 1.180 |
Why?
| | Child | 19 | 2024 | 3364 | 1.170 |
Why?
| | Reproducibility of Results | 8 | 2024 | 199 | 1.160 |
Why?
| | Heart Diseases | 2 | 2024 | 19 | 1.070 |
Why?
| | Stroke Volume | 5 | 2023 | 19 | 1.060 |
Why?
| | Female | 19 | 2024 | 3525 | 1.060 |
Why?
| | Male | 19 | 2024 | 3337 | 1.040 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2015 | 9 | 1.010 |
Why?
| | Young Adult | 11 | 2024 | 647 | 0.930 |
Why?
| | Myocardial Contraction | 2 | 2024 | 7 | 0.930 |
Why?
| | Adolescent | 14 | 2024 | 2197 | 0.900 |
Why?
| | Heart Bypass, Right | 1 | 2023 | 3 | 0.890 |
Why?
| | Physicians | 1 | 2023 | 23 | 0.890 |
Why?
| | Biomedical Research | 1 | 2023 | 27 | 0.890 |
Why?
| | Autistic Disorder | 1 | 2022 | 14 | 0.840 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 32 | 0.810 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2016 | 5 | 0.800 |
Why?
| | Infant | 8 | 2024 | 1446 | 0.750 |
Why?
| | Adult | 12 | 2024 | 1181 | 0.720 |
Why?
| | Pediatric Obesity | 1 | 2022 | 137 | 0.690 |
Why?
| | Transposition of Great Vessels | 2 | 2016 | 8 | 0.680 |
Why?
| | Coronary Vessel Anomalies | 1 | 2019 | 1 | 0.670 |
Why?
| | Sinus of Valsalva | 1 | 2019 | 2 | 0.670 |
Why?
| | Aorta | 1 | 2019 | 8 | 0.670 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 2 | 0.630 |
Why?
| | Heart | 3 | 2024 | 14 | 0.620 |
Why?
| | Retrospective Studies | 8 | 2023 | 1296 | 0.610 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2015 | 22 | 0.580 |
Why?
| | Heart Failure | 1 | 2017 | 14 | 0.580 |
Why?
| | Ventricular Function | 2 | 2022 | 5 | 0.550 |
Why?
| | Infant, Newborn | 6 | 2024 | 816 | 0.540 |
Why?
| | Follow-Up Studies | 4 | 2019 | 304 | 0.520 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 14 | 0.500 |
Why?
| | Electrocardiography | 4 | 2022 | 14 | 0.500 |
Why?
| | Sensitivity and Specificity | 4 | 2016 | 150 | 0.490 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2014 | 26 | 0.460 |
Why?
| | Prospective Studies | 4 | 2024 | 525 | 0.460 |
Why?
| | Algorithms | 1 | 2014 | 105 | 0.440 |
Why?
| | Fontan Procedure | 2 | 2023 | 19 | 0.420 |
Why?
| | Child, Preschool | 6 | 2024 | 1569 | 0.390 |
Why?
| | alpha-Glucosidases | 1 | 2011 | 1 | 0.390 |
Why?
| | Glycogen Storage Disease Type II | 1 | 2011 | 1 | 0.390 |
Why?
| | Enzyme Replacement Therapy | 1 | 2011 | 4 | 0.390 |
Why?
| | Cardiovascular Abnormalities | 1 | 2011 | 2 | 0.390 |
Why?
| | Middle Aged | 4 | 2016 | 608 | 0.340 |
Why?
| | Oxygen Consumption | 3 | 2023 | 18 | 0.330 |
Why?
| | Exercise Test | 2 | 2023 | 17 | 0.280 |
Why?
| | Electron Transport Complex IV | 2 | 2004 | 2 | 0.260 |
Why?
| | Saccharomyces cerevisiae | 2 | 2004 | 2 | 0.260 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2004 | 3 | 0.260 |
Why?
| | Systole | 3 | 2022 | 10 | 0.260 |
Why?
| | Molecular Chaperones | 2 | 2004 | 7 | 0.260 |
Why?
| | Nuclear Proteins | 2 | 2004 | 52 | 0.250 |
Why?
| | Reference Values | 2 | 2015 | 39 | 0.240 |
Why?
| | Cardiology | 1 | 2024 | 11 | 0.230 |
Why?
| | Career Choice | 1 | 2023 | 4 | 0.230 |
Why?
| | Papillary Muscles | 1 | 2023 | 1 | 0.230 |
Why?
| | Myocardium | 1 | 2023 | 8 | 0.220 |
Why?
| | Connective Tissue Diseases | 1 | 2023 | 4 | 0.220 |
Why?
| | Case-Control Studies | 1 | 2023 | 215 | 0.220 |
Why?
| | Cohort Studies | 2 | 2024 | 289 | 0.210 |
Why?
| | Obesity | 1 | 2024 | 125 | 0.210 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 3 | 0.200 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 336 | 0.200 |
Why?
| | Body Mass Index | 1 | 2022 | 157 | 0.200 |
Why?
| | Fungal Proteins | 1 | 2001 | 10 | 0.200 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2021 | 18 | 0.200 |
Why?
| | Heart Rate | 1 | 2021 | 26 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 122 | 0.180 |
Why?
| | United States | 4 | 2024 | 669 | 0.180 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2021 | 6 | 0.180 |
Why?
| | Coronary Angiography | 1 | 2019 | 2 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 16 | 0.170 |
Why?
| | Survival Rate | 2 | 2015 | 83 | 0.160 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 117 | 0.160 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2017 | 1 | 0.150 |
Why?
| | Fatal Outcome | 1 | 2017 | 7 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 2 | 2015 | 30 | 0.150 |
Why?
| | Risk Factors | 2 | 2015 | 487 | 0.140 |
Why?
| | Feasibility Studies | 2 | 2014 | 58 | 0.140 |
Why?
| | Ontario | 1 | 2015 | 1 | 0.130 |
Why?
| | Causality | 1 | 2015 | 10 | 0.130 |
Why?
| | Comorbidity | 1 | 2015 | 56 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2015 | 622 | 0.130 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2015 | 1 | 0.130 |
Why?
| | Prognosis | 1 | 2015 | 211 | 0.130 |
Why?
| | ROC Curve | 1 | 2015 | 22 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 77 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2014 | 1 | 0.120 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 8 | 0.120 |
Why?
| | Image Enhancement | 1 | 2014 | 13 | 0.120 |
Why?
| | Heart Injuries | 1 | 2012 | 3 | 0.110 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2012 | 5 | 0.110 |
Why?
| | Cardiac Catheterization | 1 | 2012 | 20 | 0.110 |
Why?
| | Age of Onset | 1 | 2011 | 28 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2011 | 44 | 0.100 |
Why?
| | Diastole | 2 | 2022 | 11 | 0.080 |
Why?
| | Time Factors | 2 | 2021 | 250 | 0.080 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 11 | 0.060 |
Why?
| | Research Design | 1 | 2024 | 63 | 0.060 |
Why?
| | Cognition | 1 | 2023 | 32 | 0.060 |
Why?
| | Exercise Tolerance | 1 | 2023 | 7 | 0.050 |
Why?
| | Oxygen | 1 | 2023 | 14 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2023 | 16 | 0.050 |
Why?
| | Registries | 1 | 2023 | 92 | 0.050 |
Why?
| | Mitral Valve | 1 | 2022 | 4 | 0.050 |
Why?
| | Vaccination | 1 | 2023 | 71 | 0.050 |
Why?
| | Exercise | 1 | 2023 | 140 | 0.050 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 1 | 0.050 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2001 | 1 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2001 | 6 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2001 | 32 | 0.050 |
Why?
| | DNA Primers | 1 | 2001 | 30 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2001 | 20 | 0.050 |
Why?
| | Mitochondria | 1 | 2001 | 11 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2021 | 115 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2001 | 115 | 0.050 |
Why?
| | Alleles | 1 | 2001 | 214 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 6 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2015 | 16 | 0.030 |
Why?
| | Software | 1 | 2015 | 30 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 99 | 0.030 |
Why?
| | Septal Occluder Device | 1 | 2012 | 2 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 2012 | 2 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2012 | 8 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 33 | 0.030 |
Why?
| | Device Removal | 1 | 2012 | 14 | 0.030 |
Why?
| | Body Weight | 1 | 2012 | 52 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 2004 | 2 | 0.020 |
Why?
| | Protein Binding | 1 | 2004 | 31 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|